Shares of Orexigen Therapeutics tumbled more than 16% in morning trading Wednesday after regulators extended by three months a review of its experimental weight loss drug treatment. The Food and Drug Administration is now expected to make a decision on Contrave,…
FDA approves Impavido to treat tropical disease leishmaniasis
The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis treatment is essential for those affected by this parasitic infection, primarily transmitted by sand fly bites. The disease occurs primarily in people who…